Formulary Coverage and Copay Program for Eligible Patients

Biogen is dedicated to identifying and implementing solutions that can help appropriate patients work through barriers to starting and staying on treatment with VUMERITY

Biogen offers a variety of resources to help your patients navigate insurance and connect them with a variety of financial resources, including: 

  • Communicating with insurance companies to clarify and confirm coverage, including assistance with the Prior Authorization process and denied claims*
  • Insurance counseling that helps the uninsured and underinsured understand government insurance programs
  • Financial assistance, including the Biogen Copay Program

Please contact your Biogen Representative or call Biogen Support Services at 1-800-456-2255 if you have any questions or concerns about patient access to VUMERITY.

*Prior Authorization is a process used by some health insurance companies in the United States to determine if they will cover a prescribed procedure, service, or medication.

Biogen Copay Program

The Biogen Copay Program may lower medication cost for eligible patients with commercial insurance.

≥85%

of commercially insured patients nationwide have coverage for VUMERITY1

brush stroke brush stroke

Effective January 1, 2021, there is an annual cap on the amount of assistance that patients can receive over a one year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. You are eligible to enroll in the Biogen Copay Program for as long as it is offered and you are treated with VUMERITY.